Published on
September 29, 2021
- 12:00 GMT
Nobilis Therapeutics Receives NIH Award to Study Xenon Inhaler for Rapid Reduction of Opioid Withdrawal Symptoms
Company is expanding its pipeline to create effective treatment for opioid addiction PORTLAND, OR, UNITED STATES, September 29, 2021 /EINPresswire.com/ -- Nobilis Therapeutics, a clinical stage biotechnology company focused on advancement of innovative …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Science
...
